THE FGFR3 MUTATION IS RELATED TO FAVORABLE PT1 BLADDER CANCER

被引：0
|
作者：
Van Rhijn, B. W. G. [1 ]
Bapat, B. [2 ]
Van Der Kwast, T. H. [3 ]
Liu, L. [2 ]
Fleshner, N. E. [1 ]
Van Der Aa, M. N. M. [4 ]
Vajpeyi, R. [1 ]
Bangma, C. H. [4 ]
Zwarthoff, E. C. [5 ]
Jewett, M. A. S. [1 ]
Zlotta, A. R. [1 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Dept Surg Oncol Urol, Toronto, ON, Canada
[2] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Univ Hlth Network, Dept Surg Pathol, Toronto, ON, Canada
[4] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[5] Erasmus MC, Dept Pathol, Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2009年 / 8卷 / 04期
关键词：
D O I：
10.1016/S1569-9056(09)60313-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [41] Role of FGFR3 in bladder cancer: Treatment landscape and future challenges
    Ascione, Claudia Maria
    Napolitano, Fabiana
    Esposito, Daniela
    Servetto, Alberto
    Belli, Stefania
    Santaniello, Antonio
    Scagliarini, Sarah
    Crocetto, Felice
    Bianco, Roberto
    Formisano, Luigi
    CANCER TREATMENT REVIEWS, 2023, 115
  • [42] The roles of FGFR3 and c-MYC in urothelial bladder cancer
    Bogale, Dereje E.
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [43] FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
    Noeraparast, Maxim
    Krajina, Katarina
    Pichler, Renate
    Niedersuess-Beke, Dora
    Shariat, Shahrokh F.
    Gruenwald, Viktor
    Ahyai, Sascha
    Pichler, Martin
    CANCER COMMUNICATIONS, 2024, 44 (10) : 1189 - 1208
  • [44] THE HYPOXIC REGULATION OF FGFR3 IN NON MUSCLE INVASIVE BLADDER CANCER
    Blick, C.
    McCormick, R.
    Ramachandran, A.
    Cranston, D.
    Catto, J. W. F.
    Harris, A. L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 167 - 167
  • [45] Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based FGFR3 Mutation Assay
    Zuiverloon, Tahlita C. M.
    Tjin, Stephen S.
    Busstra, Martijn
    Bangma, Chris H.
    Boeve, Egbert R.
    Zwarthoff, Ellen C.
    JOURNAL OF UROLOGY, 2011, 186 (02): : 707 - 712
  • [46] TP53 and FGFR3 Gene Mutation Assessment in Urine: Pilot Study for Bladder Cancer Diagnosis
    Noel, Nicolas
    Couteau, Jerome
    Maillet, Geraldine
    Gobet, Francoise
    D'Aloisio, Francoise
    Minier, Christophe
    Pfister, Christian
    ANTICANCER RESEARCH, 2015, 35 (09) : 4915 - 4921
  • [47] The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study
    van Kessel, Kim E.
    Zwarthoff, Ellen C.
    UROLOGY, 2015, 86 (06) : 1190 - 1191
  • [48] Molecular investigation of FGFR3 gene mutation and its correlation with clinicopathological findings in Indian bladder cancer patients
    Ahmad, Firoz
    Mahal, Vishal
    Verma, Geeta
    Bhatia, Simi
    Das, Bibhu Ranjan
    CANCER REPORTS, 2018, 1 (03)
  • [49] Next-gen deep sequencing improves FGFR3 mutation detection in the urine of bladder cancer patients
    Millholland, John M.
    Li, Shuqiang
    Fernandez, A.
    Shuber, Anthony P.
    CANCER RESEARCH, 2012, 72
  • [50] Mutation of FGFR3 in transitional cell carcinoma
    Sibley, K
    Kennedy, W
    Knowles, M
    BRITISH JOURNAL OF CANCER, 2001, 85 : 79 - 79
12345